1stOncology™, the leading oncology drug development surveillance and analysis platform from BioSeeker Group, now fully supports the latest release of the GLOBOCAN database (September 2018) which includes estimates of the incidence, mortality and prevalence from 36 types of cancer and for all cancers combined in 185 countries of the world. The estimates are presented for 2018, separately for each sex and for the 18 traditional age-groups.

The online tool allows the production of tables and visual descriptions of the current cancer burden by country or region, and permits projections regarding future cancer burden over the next 20 years.

Log-in here to access GLOBOCAN 2018 Epidemiology Data in 1stOncology™ or, if you are not a current user, request a free demo here to learn more.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!